Ponoi II Management, LLC
- SEC CIK
- 0001746488
- Latest filing
- Nov 14, 2022
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 4
- −1 vs. Q2 2021
- Portfolio value
- $67.5M
- −$55.9M (−45.3%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $27.3M | 40.5% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $18.8M | 27.9% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 561,574 | $16.8M | 24.9% | −124,700−18.2% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 145,401 | $4.51M | 6.7% | 00.0% | Unchanged | History |
Sold out since Q2 2021 (1)
Positions held at the end of Q2 2021 that are gone from this filing.